← Tra cứu cổ phiếu

iShareInvest Research

UPCOM · Quý 2/2026

UPH

Dược phẩm TW 25

Analysis of business results & financial statements · Quý 2/2026

▲▲ Improving positively

Trailing net profit reached 5.1bn, rose 3.4bn compared with the same period last year. Key positives came from higher gross profit, higher financial income, and lower selling expenses. Offsetting pressure came mainly from higher administrative expenses. Detailed impact is shown below:

See what is changing ↓
P/E
—
P/B
—
EPS
—
BVPS
—
ROE
3.2%
ROA
1.4%
Market price
7,200
16 Oct 2026

What Is Changing

On a TTM 2026Q2 basis, UPH has not accelerated revenue sharply, but profitability is improving visibly — profit momentum has been slowing across consecutive periods. However, a significant portion of profit is supported by non-core sources, making the picture not entirely clear.

Profit bridge

Vs last year · TTM

  1. Gross profit
  2. Financial income
  3. Selling expenses
  4. Administrative expenses
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue19.426.046.726.920.518.846.724.4
LNST2.50.61.60.5-0.10.31.20.4
Net margin12.83%2.14%3.38%1.89%-0.53%1.53%2.58%1.44%

Revenue

19bn

Net income

2bn

Net margin

12.83%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins improved (+2.7pp), but earnings still rely significantly on non-core sources — warrants closer scrutiny.

Revenue Growth

▲

Is growth real and durable?

Trailing-12-month revenue grew 7.7% year on year — but the quarterly pace is slowing (+10% → −6%).

2 of the last 4 quarters grew year on year.

Revenue TTM
119bn
+7.7%
Latest quarter YoY
−6%
slowing

What is driving the margin?

▲

Net margin expanded to 4.31%, rising 2.7pp. Core operating signals are improving as Gross margin rose 4.7pp are enough to offset pressure from SG&A / Revenue rose 0.4pp (with additional support from Net financial result / Revenue rose 0.3pp).

The improvement comes from core operations — this is a high-quality margin expansion.

Net Margin
4.31%
+2.7pp
Gross Margin
16.64%
+4.7pp
SG&A / Revenue
13.35%
+0.4pp
Non-core / Revenue
2.49%
+0.3pp

TTM YoY · 2025Q2 -> 2026Q2

Financial result is supporting margin

Margin support from financial result remains high (42.1% of PBT) — sustainability should be monitored.

Cash Flow

▲▲

Is profit converting into cash?

With leverage safe, cash flow shows the self-funding capacity. Operating cash flow reached 7.5bn against investing cash flow of 13.6bn (annual cash-flow figures for 2025).

Post-investment cash flow was positive +21.1bn. Financing cash flow was positive 0.0bn.

CFO / net income was 3,12 lần.

After spending +1.8bn on fixed-asset investment, the business generated trailing free cash flow of +14.2bn.

Earnings Quality

▼

How much income is non-core?

Non-core income reaches 42.1% of pre-tax profit — core earnings are thinner than the headline.

Within that, net financial result at +42.1% of PBT.

Non-core / PBT
42.1%
high
Net financial / PBT
42.1%
02

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Working Capital Efficiency

▲

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 9.4 days versus the same period last year. The main moves came from DIO rose 12.7 days, DSO fell 28.8 days, and DPO fell 6.7 days.

Improvement comes mainly from faster receivables collection — reflects the quality of receivables management.

Cash conversion cycle remains stretched

CCC stands at 867.4 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Inventory turnover is slowing

DIO increased by +12.7 days, suggesting more capital is being tied up in inventories.

DuPont

What drives ROE?

Net margin 4.3% +2.7pp
Asset turnover 0.32x +0.02x
Financial leverage 2.38x -0.07x
ROE 3.2% +2.1pp

ROE rose from 1.1% to 3.2% — mainly driven by net margin, despite leverage moving in the opposite direction.

03

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 7.5bn.

Leverage & Liquidity

▲

Track net leverage, interest coverage, and the liquidity buffer on the balance sheet.

Debt maturity and the cash buffer remain the two key areas to monitor.

Some leverage signals are missing, so the current read should be treated as contextual.

Net Debt / Equity
−0.08x
Interest Coverage
None
Cash / Debt
None
Short-term Debt / Total Debt
None

TTM YoY · 2025Q2 -> 2026Q2

Balance Sheet

▲

Balance sheet is exceptionally sound — liabilities at 1.46x equity, with a net cash position equivalent to 0.08x equity.

Inventory ended the period at 191.3bn, roughly 49.3% of total assets.

Over the last 12 months, working capital released 9.2bn of cash, mainly thanks to lower receivables and higher payables. Pressure from higher inventories only partly offset that benefit.

Research synthesis

What this reporting period is showing

The business is showing a brighter picture at the headline-earnings level, but what deserves a closer look right now is the quality of that improvement. Margins and net profit may look better, but if financial income, other income, or unusually low taxes contribute too much, this is not yet a clean enough growth base to extrapolate further. The main bright spot is operating efficiency, with net margin improving 2.7 pp. Even so, the earnings mix still warrants monitoring in upcoming periods, when non-core contribution is 42.1%. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 867 days.

  • Improvement: operating efficiency is getting better, with trailing-12M net margin at 4.31% after expanding 2.7pp versus the same period last year.
  • Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 3.12x. Even so, net financial result still accounts for 42.1% of PBT, so the earnings mix still needs monitoring.
  • Key risk: working capital remains tied up for too long, with cash cycle at 867.4 days.

Questions for the next period

  1. Whether revenue sustains its +7,7% YoY pace or begins to slow.

  2. Whether margins hold around the current 4.31% level or narrow again.

  3. Whether operating cash flow holds its 7.5bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio